Cargando…

A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli

Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Goor, Angelica, Stromberg, Zachary R., Mellata, Melha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570496/
https://www.ncbi.nlm.nih.gov/pubmed/28837660
http://dx.doi.org/10.1371/journal.pone.0183929
_version_ 1783259188739178496
author Van Goor, Angelica
Stromberg, Zachary R.
Mellata, Melha
author_facet Van Goor, Angelica
Stromberg, Zachary R.
Mellata, Melha
author_sort Van Goor, Angelica
collection PubMed
description Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment, condemnation of products, and death. In this study, we evaluated a recombinant antigens (rAg) vaccine combining common ExPEC surface proteins EtsC, OmpA, OmpT, and TraT for broad protective potential against APEC infections in chickens. The specific objectives were to evaluate antibody (serum) and cytokines (lymphoid organs) responses to vaccination; in vitro bactericidal ability of serum and splenocytes against multiple APEC serotypes; and in vivo protection against APEC challenge in chickens. Groups of four-day old chickens (N = 10) were vaccinated twice (two-week interval) subcutaneously with rAgs alone or in combination and CpG adjuvant or PBS (control). IgY antibody in the serum and mRNA expression of IL-1β, IL-6, IL-18, IFN-γ, IL-4, IFN-β, and IL-8 in bursa, spleen, and thymus were measured using ELISA and RT-qPCR, respectively. Serum and splenocytes were tested for their bactericidal ability in vitro against multiple APEC isolates. Vaccinated and non-vaccinated chickens were challenged with 10(8) CFU of APEC-O2 via air sac at 31 days post first vaccination. Vaccine protection was determined by the decrease of bacterial loads in blood and organs (lung, heart, spleen, and liver), as well as gross colibacillosis lesion scores in air sac, heart, and liver. Vaccination significantly (P < 0.05) elicited IgY against specific antigens, induced immune related mRNA expression in the spleen and bursa, reduced in vitro growth of multiple APEC serotypes, and decreased bacterial loads in the heart and spleen, and gross lesion scores of the air sac, heart and liver in chickens. The vaccine reported may be used to provide broad protection against APEC strains, increasing animal welfare and food production.
format Online
Article
Text
id pubmed-5570496
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55704962017-09-09 A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli Van Goor, Angelica Stromberg, Zachary R. Mellata, Melha PLoS One Research Article Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment, condemnation of products, and death. In this study, we evaluated a recombinant antigens (rAg) vaccine combining common ExPEC surface proteins EtsC, OmpA, OmpT, and TraT for broad protective potential against APEC infections in chickens. The specific objectives were to evaluate antibody (serum) and cytokines (lymphoid organs) responses to vaccination; in vitro bactericidal ability of serum and splenocytes against multiple APEC serotypes; and in vivo protection against APEC challenge in chickens. Groups of four-day old chickens (N = 10) were vaccinated twice (two-week interval) subcutaneously with rAgs alone or in combination and CpG adjuvant or PBS (control). IgY antibody in the serum and mRNA expression of IL-1β, IL-6, IL-18, IFN-γ, IL-4, IFN-β, and IL-8 in bursa, spleen, and thymus were measured using ELISA and RT-qPCR, respectively. Serum and splenocytes were tested for their bactericidal ability in vitro against multiple APEC isolates. Vaccinated and non-vaccinated chickens were challenged with 10(8) CFU of APEC-O2 via air sac at 31 days post first vaccination. Vaccine protection was determined by the decrease of bacterial loads in blood and organs (lung, heart, spleen, and liver), as well as gross colibacillosis lesion scores in air sac, heart, and liver. Vaccination significantly (P < 0.05) elicited IgY against specific antigens, induced immune related mRNA expression in the spleen and bursa, reduced in vitro growth of multiple APEC serotypes, and decreased bacterial loads in the heart and spleen, and gross lesion scores of the air sac, heart and liver in chickens. The vaccine reported may be used to provide broad protection against APEC strains, increasing animal welfare and food production. Public Library of Science 2017-08-24 /pmc/articles/PMC5570496/ /pubmed/28837660 http://dx.doi.org/10.1371/journal.pone.0183929 Text en © 2017 Van Goor et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Van Goor, Angelica
Stromberg, Zachary R.
Mellata, Melha
A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli
title A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli
title_full A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli
title_fullStr A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli
title_full_unstemmed A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli
title_short A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli
title_sort recombinant multi-antigen vaccine with broad protection potential against avian pathogenic escherichia coli
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570496/
https://www.ncbi.nlm.nih.gov/pubmed/28837660
http://dx.doi.org/10.1371/journal.pone.0183929
work_keys_str_mv AT vangoorangelica arecombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli
AT strombergzacharyr arecombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli
AT mellatamelha arecombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli
AT vangoorangelica recombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli
AT strombergzacharyr recombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli
AT mellatamelha recombinantmultiantigenvaccinewithbroadprotectionpotentialagainstavianpathogenicescherichiacoli